Cite
MLA Citation
Tim W Harrison et al.. “Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.” Lancet, vol. 9, no. 3, 2021, pp. 260–274. http://access.bl.uk/ark:/81055/vdc_100123118667.0x000014